Evidence map›Paper›PMID 42388574›Full record

ArticleEuropean oral research2026

Effect of chromogenic beverages on color stability and surface roughness of CAD/CAM resin-matrix ceramics: an in vitro study.

Tuğba Nur Öztürk, Esra Yıldız

Abstract read
In one paragraph

Article in European oral research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tuğba Nur ÖztürkDepartment of Restorative DentistryInstitute of Graduate Studies in Health SciencesIstanbul University Istanbul Turkey.ORCID https://orcid.org/0000-0003-0697-3738
Esra YıldızDepartment of Restorative DentistryFaculty of DentistryIstanbul University Istanbul Turkey.ORCID https://orcid.org/0000-0002-4816-0981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study evaluated the effects of commonly consumed chromogenic beverages on the color stability and surface roughness of three CAD/CAM resin-matrix ceramics at different time intervals. The study aims to provide comparative data under standardized immersion conditions, addressing a gap in time-dependent color and surface alterations of CAD/CAM resin-matrix ceramics. Materials and Methods: A total of 168 specimens were prepared from three CAD/CAM resin-matrix ceramics (Vita Enamic HT 2M2, Cerasmart HT A2, and Brava HT A2). Specimens were immersed in distilled water, coffee, cola, or red wine at 37 °C for up to 12 days. Color (ΔE₀₀, CIE L*a*b*), and surface roughness (Ra) were measured at baseline, 3, 6, and 12 days. Two-way repeated-measures ANOVA (factors: beverage and time) followed by post-hoc tests (α=0.05) was used for statistical analysis. Results: Red wine produced the highest color change in all materials (p<0.001), followed by coffee, whereas cola and water resulted in significantly lower ΔE₀₀ values. At day 12, Vita Enamic showed greater discoloration and roughness than Cerasmart and Brava (p<0.05). Both ΔE₀₀ and Ra increased significantly with time (p<0.001). Conclusion: Exposure to chromogenic beverages significantly affected both color stability and surface roughness of CAD/CAM resin-matrix ceramics. Red wine and coffee were the most aggressive agents, while Cerasmart demonstrated the best stability. Routine dietary counseling and periodic repolishing may be advisable to preserve the long-term esthetic integrity of CAD/CAM restorations.

Indexed as

CAD/CAM resin-matrix ceramicschromogenic beveragescolor stabilitysurface roughness

Identifiers

PMID42388574
PMCPMC13319652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.